Active substance
Sennosides
- SFDA 2
- US price lines 1
- NHS prices 1
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| PURGATON | 20 mg | Tablet · Oral use | 30 Blister | SAR 5.10 | Generic · OTC | MEMPHIS CHEMICALS | Withdrawn by regulatory authority · Not Marketed |
| PURSENNID TABLET | 12 mg | Tablet · Oral use | 20 Blister | SAR 6.35 | Generic · OTC | NOVARTIS | Withdrawn by MAH · Not Marketed |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | SENNOSIDES 8.6 MG TABLET | $0.0258 | per EA | 23 Sep 2026 |
| NHS Drug Tariff | Sennosides 7.5mg/5ml oral solution sugar free | £11.70 | 500 ml | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Combinations containing Sennosides
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.